ZHANG Xue-mei, YANG She-qin. Efficacy and Clinical Analysis of Fuxin Decoction in Treatment of Heart Failure[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(17): 206-208.
DOI:
ZHANG Xue-mei, YANG She-qin. Efficacy and Clinical Analysis of Fuxin Decoction in Treatment of Heart Failure[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(17): 206-208. DOI: 10.13422/j.cnki.syfjx.2014170206.
Efficacy and Clinical Analysis of Fuxin Decoction in Treatment of Heart Failure
目的:探讨复心汤治疗心衰的临床疗效,为进一步的临床治疗提供参考依据。方法:2012年12月至2013年12月期间,本院诊治的120例心衰患者,随机将其分为对照组(强心、利尿等常规抗心衰治疗)和观察组(在对照组治疗基础上,加用复心汤),每组各60例,观察和比较两组心功能疗效、中医证候评分疗效、不良反应、治疗前后左室舒张末期内径(LVEDD)、左室射血分数(LVEF)、血流舒张早期与心房收缩期峰值速率比(E/A值)。结果:与对照组相比,观察组心功能总有效率(96.7% vs 86.7%)、中医证候评分总有效率(91.7% vs 73.3%)均明显升高,不良反应发生率显著降低(1.7% vs 13.3%),P<0.05;与对照组相比,治疗后观察组LVEF(47.0±1.0 vs 44.4±1.2),E/A值(1.3±0.4 vs 1.0±0.3)均明显提高(P<0.05)。结论:复心汤治疗心衰的疗效显著,明显改善患者的心功能和预后质量,并且不良反应少,具有较高治疗安全性,值得临床推广。
Abstract
Objective: The purpose of this research was to study the clinical efficacy of Fuxin decoction in the treatment of heart failure
and provide the reference basis for the future clinical treatment. Method: One hundred and twenty patients with heart failure cured in our hospital from Feb 2012 to Dec 2013 were randomized into the control group (treated with the routine anti-heart failure therapy such as strong heart and dieresis) and the observation group (Fuxin decoction added based on the control group)
with 60 patients per group. The efficacy of heart function
traditional Chinese medicine(TCM) syndrome scores
adverse reactions
left ventricular end diastolic diameter (LVEDD)
left ventricular ejection fraction (LVEF) and E/A value on pre-and post-treatment in the two groups were observed and compared. Result: compared with the control group
the heart function efficacy (96.7% vs 86.7%) and the TCM syndrome scores efficacy (91.7% vs 73.3%)were significantly increased
the incidence of adverse reactions was obviously reduced (1.7% vs 13.3%)in the observation group
P<0.05;compared with the control group
the LVEF(47.0±1.0 vs 44.4±1.2)and E/A values (1.3±0.4 vs 1.0±0.3)were significantly increased in the post-treatment in the observation group
P<0.05. Conclusion: The efficacy of Fuxin decoction in the treatment of heart failure is significant
it can improve the patient's heart function and prognosis quality with less adverse reactions and higher treatment safety
Efficacy of Shexiang Tongxin Dropping Pills in Treatment of Coronary Slow Flow and Its Effect on Inflammatory Factors
Pathogenesis and Syndrome Differentiation Treatment of Heart Failure Based on "Spleen-mitochondria" and Theory of "Dampness, Turbidity, Phlegm, and Fluid-related Diseases"
Efficacy and Safety of Lianhua Qingwen Preparation in Treatment of Community-acquired Pneumonia:A Systematic Review and Meta-analysis
Systematic Review and Meta-Analysis of Efficacy and Safety of Linggui Zhugantang Combined with Conventional Drugs in Delaying Course of Heart Failure
Clinical Observation and Research on Prevention and Treatment of Epilepsy Complicated with Cognitive Impairment by Quyu Dingxian Zhengtong Mixture for Dispelling Stasis and Resolving Phlegm
Related Author
NIU Chaofeng
ZHANG Peiyu
LI Meng
WEI Lan
DONG Juwei
MA Liyong
ZHUANG Rui
ZHANG Lijing
Related Institution
Dongzhimen Hospital, Beijing University of Chinese Medicine
The Second Affiliated Hospital of Tianjin University of TCM
Tianjin University of Traditional Chinese Medicine(TCM)
The Second Hospital of Hebei Medical University
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University